In Remission

In this video series, presented in March of 2021, GRACE Board Members Dr. H. Jack West, Dr. Jared Weiss and Dr. Ben Levy have continued candid discussions regarding cancer and COVID-19.

In this continued time of social distancing and limiting clinic exposure, the doctors sat down in their respective homes to discuss some of the questions we all hear regarding these unprecedented times, and how they effect primarily cancer patients.

In this video the discussion is surrounding the continued use of telemedicine in cancer treatment.

In this video series, presented in March of 2021, GRACE Board Members Dr. H. Jack West, Dr. Jared Weiss and Dr. Ben Levy have continued candid discussions regarding cancer and COVID-19

In this continued time of social distancing and limiting clinic exposure, the doctors sat down in their respective homes to discuss some of the questions we all hear regarding these unprecedented times, and how they effect primarily cancer patients.

GRACE is excited to bring you a new series on current updates in Melanoma Treatment

Meredith McKean MD, MPH with Tennessee Oncology, Michael Postow, MD Chief of Melanoma service at Memorial Sloan Kettering and Sanjiv Agarwala, MD, Professor of Medical Oncology and Hematology at Temple University School of Medicine in Easton, PA joined GRACE to discuss current updates in treatment for Melanoma.   

In this video, Dr. McKean discusses combination immunotherapy vs. monotherapy for Metastatic Melanoma.

Telemedicina y telesalud: cómo COVID 19 ha transformado la atención del cáncer

¿Qué sabemos sobre los efectos del COVID-19 en latinos con cáncer? Actualizaciones y recomendaciones.

(SPANISH) ¿Cómo ha afectado el COVID-19 el diagnóstico de cáncer y qué puede hacer usted al respecto? Es hora de recordar la importancia de la detección temprana.

GRACE is excited to share with you a partnership with Lilly Oncology to provide you information that reflects our shared interests. 

We are happy to launch our Partnership Page with Lilly Oncology, available at https://cancergrace.org/sponsor/lilly-2020.  This partnership highlights past and present GRACE information featuring our shared interests. 

From the Targeted Therapies Patient Forum 2019, Dr. Joshua Bauml and Dr. Joshua Sabari discuss RET, MET and BRAF, the initial treatment and acquired resistance.

To join the conversation, visit https://cancergrace.org/forum.